Clemson Greenwood Genetics and receive first round of funds CHPR -
Seven research projects of faculty and Greenwood Genetic Center of Clemson University have been selected to receive the first round funding provided by regional auto Healthcare (CHPR).
in February, CHPR announced a partnership with Clemson and GGC to serve as the main hospital partner collaboration. As part of this commitment, the hospital has pledged a total of $ 5.6 million for the project, of which $ 1.2 million per year for three years to fund genetic research.
Fourteen projects were submitted to the faculty at both Greenwood Genetic Center and Clemson University. Each project was evaluated by an independent team, and final selections were announced this week by Dr. Steve Skinner, director of the Greenwood Genetic Center, and Steve Kresovich, Robert and Lois Coker Trustees Chair in Genetics / SmartState president of genomics Clemson.
Five of funded projects focus on understanding and treatment of autism spectrum disorders, while two proposals were combined to investigate the improved diagnosis for hereditary cancers.
"the mixture of research teams of both Clemson and GGC will enable our institutions to build on the strengths of each other," said Skinner. "The commitment of regional autonomy in support of these efforts is an essential part of understanding, and ultimately, treatment, disorders such as autism and cancer which affect so many families."
Each selected project includes team members both Clemson and Greenwood genetic Center, the following proposals were funded.
Modi Wetzler of Clemson department of chemistry is going to work on development of a therapy for autistic patients who have a known specific mutation
LJ Wang Clemson's department of genetics and biochemistry. will identify the genetic changes across the genome that are associated autism spectrum disorders.
Charles Schwartz, GGC director of research, analyze stem cells and neuronal cells to better understand their impact in autism.
Luigi Boccuto, assistant researcher at GGC, will expand its work on understanding the biochemical basis of autism by studying the metabolism of tryptophan.
Anand Srivastava, associate director of GGC research will investigate the genetic and metabolic targets for the treatment of autism.
Julia Eggert from Clemson University School of Nursing and Alka Chaubey, Director of Cytogenetics Laboratory GGC, combined their proposals to explore the use of new technologies to identify genetic mutations in cancer patients .
"This announcement launches a new chapter between Clemson University and Greenwood Genetic Center in linking research and educational opportunities to solve urgent problems of human health while creating new opportunities .. economic development, "said Kresovich
Chaubey, one of the grant recipients, said:" We are all looking forward to starting this new joint research phase of this collaboration allows us to not only do. progress in areas such as autism which we have been actively studied for many years, but also provides the opportunity to expand our efforts in other areas such as oncology. "
EmoticonEmoticon